Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Virpax Pharmaceuticals | 8-K: VIRPAX PHARMACEUTICALS REPORTS 2024 SECOND QUARTER RESULTS AND RECENT DEVELOPMENTS
Virpax Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Su Judy
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | D: Filing D
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Field Katharyn
Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Field Katharyn
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Herman Gary L
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dhaliwal Jatinder
Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Herman Gary L
Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Dhaliwal Jatinder
Virpax Pharmaceuticals | DEFA14A: Others
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 8-K: Current report
No Data